Research Topics
| R E PeschelSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Long-term complications with prostate implants: iodine-125 vs. palladium-103R E Peschel
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
Radiat Oncol Investig 7:278-88. 1999..The implications of these findings are discussed in terms of future research directions for prostate implants...
Long-term outcomes after prostate implant: Wheeling, WVRichard E Peschel
Department of Therapeutic Radiology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8040, USA
Cancer J 13:78-9. 2007
Prostate implant therapy: iodine-125 versus palladium-103Richard E Peschel
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Cancer J 11:383-4. 2005
PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patientsR E Peschel
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
Int J Cancer 90:29-36. 2000..Int. J. Cancer (Radiat. Oncol. Invest.) 90, 29-36 (2000)...
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005John W Colberg
Departments of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA
Cancer J 13:229-32. 2007....
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complicationsRichard E Peschel
Department of Therapeutic Radiology, Yale University School of Medicine, HRT 136, 333 Cedar Street, New Haven, CT 06510, USA
Cancer J 10:170-4. 2004..Although specific dosimetric comparisons are not valid given differences in imaging over the study course, the complication rate appears to be somewhat higher for (125)I, which is consistent with a radiobiologic model...
Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancerRichard E Peschel
Section of Urology, Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA
Lancet Oncol 4:233-41. 2003..On the basis of current data, we recommend specific treatment options...
The effect of age on prostate implantation resultsRichard E Peschel
Department of Therapeutic Radiology, Urology Section, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Cancer J 12:305-8. 2006....
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinomaAyal A Aizer
Department of Radiation Oncology, Yale School of Medicine, New Haven, CT, USA
Int J Radiat Oncol Biol Phys 75:1344-9. 2009..To determine whether whole pelvic radiotherapy (WPRT) or prostate-only radiotherapy (PORT) yields improved biochemical disease-free survival (BDFS) in patients with advanced or aggressive prostate adenocarcinoma...
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinomaAyal A Aizer
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA
Radiother Oncol 93:185-91. 2009....
Validation of the partin nomogram for prostate cancer in a national sampleJames B Yu
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA
J Urol 183:105-11. 2010..The nomogram is based on patients undergoing radical prostatectomy at The Johns Hopkins Medical Institutions. We validated the Partin tables in a large, population based sample...
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapyAyal A Aizer
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
Int J Radiat Oncol Biol Phys 79:379-84. 2011..To assess the impact of pretreatment prostate volume on the development of severe acute genitourinary toxicity in patients undergoing intensity-modulated radiation therapy (IMRT) for prostate cancer...
